Reviva Pharmaceuticals Holdings's market cap is currently $75.92M. The company's EPS TTM is $-1.106; its P/E ratio is ―; Reviva Pharmaceuticals Holdings is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Mar 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ -724.74K	$ 0.00
Operating Income	$ -39.50T	$ -24.31M	$ -10.10M	$ -2.43M	$ -376.86K
EBITDA	$ -39.50T	$ -24.11M	$ -10.10M	$ -2.33M	$ -376.01K
Net Income	$ -39.26T	$ -24.34M	$ -8.52M	$ -3.78M	$ -846.83K
Balance Sheet
Cash & Short-Term Investments	$ 23.37M	$ 18.52M	$ 29.69M	$ 8.76M	$ 193.00
Total Assets	$ 23.70M	$ 18.92M	$ 31.40M	$ 8.76M	$ 2.60K
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 3.77M
Net Debt	$ -23.37M	$ -18.52M	$ -29.69M	$ -8.76M	$ 3.76M
Total Liabilities	$ 17.98M	$ 6.61M	$ 2.72M	$ 1.33M	$ 6.81M
Stockholders' Equity	$ 5.72M	$ 12.32M	$ 28.69M	$ 7.43M	$ -6.81M
Cash Flow
Free Cash Flow	$ -28.32M	$ -18.96M	$ -10.67M	$ -3.73M	$ -218.44K
Operating Cash Flow	$ -28.32M	$ -18.96M	$ -10.67M	$ -3.73M	$ -218.44K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 33.17M	$ 7.79M	$ 31.60M	$ 12.83M	$ 100.00K

Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

Income Statement >

Reviva Pharmaceuticals Holdings Debt to Assets

Balance Sheet >

Reviva Pharmaceuticals Holdings Cash Flow

Cash Flow >

Reviva Pharmaceuticals Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing